xencor.com - XNCR Net Assets per Single Share

The market value dynamics of Xencor, Inc. (XNCR) on the GURU.Markets platform, which currently stands at 6.72, illustrate the business development of tumor-fighting immunotherapies. Xencor, Inc. (XNCR) is fighting for leadership in a segment dominated by behemoths with colossal resources. Effective management skillfully monetizes developments through strategic alliances. The environmental profile is standard, adhering to the safe disposal of chemicals and sustainable resource consumption.

XNCR: Xencor Corp Net Asset Value per Share 07/04/2022 - 10/27/2026

xencor.com - analytical breakdowns and key metrics (XNCR)

- price and consensus price forecast:

Stock Price Xencor Corp|XNCR - Consensus Target

- market capitalization data:

Market Value Xencor, Inc.|XNCR - Value Adjusted for Debt and Cash

- book capitalization data:

Net Assets per Single Share Xencor|XNCR - Total Stockholders' Equity|Market Value to Book Value Ratio xencor.com|XNCR - Total Business Assets

- debt and liquidity data:

Total Debt to Capital Xencor, Inc.|XNCR - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Xencor|XNCR - Company Cumulative Debt|Debt to Book Capitalization Ratio Xencor, Inc.

Fundamental company valuation:XNCR - Xencor Corp

Xencor, Inc. (XNCR) develops unique protein platforms, monetizing them through stable licensing agreements with pharmaceutical behemoths. The book value per share is calculated as the difference between all assets and liabilities, divided by the number of shares. By analyzing the book value per share trend, an investor can see the real dynamics of equity accumulation. Growth in this metric confirms the expansion of the material base regardless of macro cycles. Positive dynamics strengthen the fundamental stability of the business.

Competitor analysis for Xencor, Inc.